Clinical Benefits with Oseltamivir in Treating Influenza in Adult Populations: Results of a Pooled and Subgroup Analysis

Author： Singh S.

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.9, 2003-01, pp. : 561-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Efficacy of Inhaled Zanamivir for the Treatment of Patients with Influenza B Virus Infection: A Pooled Analysis of Randomised, Placebo-Controlled Studies

By Osterhaus A.D.M.E.

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 223-228

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic assessment of oseltamivir in treating influenza – the case of otherwise healthy Danish adolescents and adults

By Holm Majbrit Gyldmark Marlene Hansen Ebba

Pharmacy World and Science, Vol. 26, Iss. 6, 2004-12 ,pp. : 339-345

Springer Publishing Company

Access to resources Recommend Favorite

Oseltamivir in the management of influenza

By Oxford John

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2493-2500

Informa Healthcare

Access to resources Recommend Favorite

Oseltamivir: A Review of its Use in Influenza

By McClellan K. Perry C.M.

Drugs, Vol. 61, Iss. 2, 2001-01 ,pp. : 263-283

Adis International

Access to resources Recommend Favorite